cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.5517/cc7qltb
title: CCDC 230262: Experimental Crystal Structure Determination

description: Related Article: F.Glorius, N.Spielkamp, S.Holle, R.Goddard, C.W.Lehmann|2004|Angew.Chem.,Int.Ed.|43|2850|doi:10.1002/anie.200453942
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/cc7qlvc
title: CCDC 230263: Experimental Crystal Structure Determination

description: Related Article: F.Glorius, N.Spielkamp, S.Holle, R.Goddard, C.W.Lehmann|2004|Angew.Chem.,Int.Ed.|43|2850|doi:10.1002/anie.200453942
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/cc7qlwd
title: CCDC 230264: Experimental Crystal Structure Determination

description: Related Article: F.Glorius, N.Spielkamp, S.Holle, R.Goddard, C.W.Lehmann|2004|Angew.Chem.,Int.Ed.|43|2850|doi:10.1002/anie.200453942
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/cc7qlxf
title: CCDC 230265: Experimental Crystal Structure Determination

description: Related Article: F.Glorius, N.Spielkamp, S.Holle, R.Goddard, C.W.Lehmann|2004|Angew.Chem.,Int.Ed.|43|2850|doi:10.1002/anie.200453942
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/cc7qlyg
title: CCDC 230266: Experimental Crystal Structure Determination

description: Related Article: F.Glorius, N.Spielkamp, S.Holle, R.Goddard, C.W.Lehmann|2004|Angew.Chem.,Int.Ed.|43|2850|doi:10.1002/anie.200453942
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/cc7qlzh
title: CCDC 230267: Experimental Crystal Structure Determination

description: Related Article: F.Glorius, N.Spielkamp, S.Holle, R.Goddard, C.W.Lehmann|2004|Angew.Chem.,Int.Ed.|43|2850|doi:10.1002/anie.200453942
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/cc7qxhb
title: CCDC 230562: Experimental Crystal Structure Determination

description: Related Article: T.Kato, C.A.Reed|2004|Angew.Chem.,Int.Ed.|43|2908|doi:10.1002/anie.200453931
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/cc7qxjc
title: CCDC 230563: Experimental Crystal Structure Determination

description: Related Article: T.Kato, C.A.Reed|2004|Angew.Chem.,Int.Ed.|43|2908|doi:10.1002/anie.200453931
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/cc7qxkd
title: CCDC 230564: Experimental Crystal Structure Determination

description: Related Article: T.Kato, C.A.Reed|2004|Angew.Chem.,Int.Ed.|43|2908|doi:10.1002/anie.200453931
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/cc7snwj
title: CCDC 232248: Experimental Crystal Structure Determination

description: Related Article: A.V.Kurnosov, V.Yu.Komarov, V.I.Voronin, A.E.Teplykh, A.Yu.Manakov|2004|Angew.Chem.,Int.Ed.|43|2922|doi:10.1002/anie.200453712
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/cc7hvcx
title: CCDC 223769: Experimental Crystal Structure Determination

description: Related Article: C.Seward, Wen-Li Jia, Rui-Yao Wang, G.D.Enright, Suning Wang|2004|Angew.Chem.,Int.Ed.|43|2933|doi:10.1002/anie.200353126
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/cc7hvdy
title: CCDC 223770: Experimental Crystal Structure Determination

description: Related Article: C.Seward, Wen-Li Jia, Rui-Yao Wang, G.D.Enright, Suning Wang|2004|Angew.Chem.,Int.Ed.|43|2933|doi:10.1002/anie.200353126
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/cc7nnr8
title: CCDC 228400: Experimental Crystal Structure Determination

description: Related Article: A.Srinivasan, T.Ishizuka, H.Maeda, H.Furuta|2004|Angew.Chem.,Int.Ed.|43|2951|doi:10.1002/anie.200453732
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/cc7nns9
title: CCDC 228401: Experimental Crystal Structure Determination

description: Related Article: A.Srinivasan, T.Ishizuka, H.Maeda, H.Furuta|2004|Angew.Chem.,Int.Ed.|43|2951|doi:10.1002/anie.200453732
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/cc7h7xv
title: CCDC 223197: Experimental Crystal Structure Determination

description: Related Article: D.Scheschkewitz|2004|Angew.Chem.,Int.Ed.|43|2965|doi:10.1002/anie.200353347
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/cc7nntb
title: CCDC 228402: Experimental Crystal Structure Determination

description: Related Article: A.Srinivasan, T.Ishizuka, H.Maeda, H.Furuta|2004|Angew.Chem.,Int.Ed.|43|2951|doi:10.1002/anie.200453732
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/cc7r7v1
title: CCDC 230883: Experimental Crystal Structure Determination

description: Related Article: E.Coronado, C.Gimenez-Saiz, C.J.Gomez-Garcia, S.C.Capelli|2004|Angew.Chem.,Int.Ed.|43|3022|doi:10.1002/anie.200453985
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.34740/kaggle/dsv/13346694
title: Peer-to-Peer Boliviano (BOB) Exchange Data
DOI: 10.21979/n9/7stu9y
title: Enhancing Bifunctionality of CoN Nanowires by Mn Doping for Long-lasting Zn-Air Batteries

description: In this work, we deploy the effective strategy of Mn doping to improve both OER and ORR activity of CoN nanowires as the cathode material for ZAB
DOI: 10.21979/n9/cjtom7
title: Histogram of Agreements Between LWRM1 and RAKE for ACM-TWEB Corpus

description: Python script to plot the histogram comparing the agreement between LWRM1 and RAKE for the ACM-TWEB corpus.
DOI: 10.15468/dl.unvzk5
title: Occurrence Download

description: A dataset containing 30 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Trixis glaziovii",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 {
 "not" : {
 "BasisOfRecord" : [
 "is Fossil"
 ]
 }
 }
 ]
}

 The dataset includes 30 records from 16 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0003321-260226173443078/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.17605/osf.io/rbc6s
title: Emergent climatic controls on soil carbon turnover and its variability in warm climates

description: The dataset includes the observation-based data of climate variables (mean annual temperature, mean annual precipitation, and potential evapotranspiration), soil carbon stocks, soil mean carbon age, and soil carbon turnover time in global warm regions.
DOI: 10.15468/dl.y2v4cv
title: Occurrence Download

description: A dataset containing 270 records in GBIF matching the query:

SELECT
 GBIF_ISEA3HCode(
 8, 
 decimalLatitude,
 decimalLongitude,
 COALESCE(coordinateUncertaintyInMeters, 1000)
 ) AS geogrid_id,
 CASE 
 WHEN classKey IN ('359') THEN 'Mammals'
 WHEN classKey IN ('212') THEN 'Birds'
 WHEN familyKey IN ('1103', '1104', '494', '495', '1105', '496', '497', '1106', '498', '499', '1107', '537', '538', '1153', '547', '1162', '548', '549', '550', '1163', '1164', '1165', '1166', '1167', '1305', '1067', '1306', '1307', '1308', '1068', '1069', '587', '1310', '588', '589', '1311', '1312', '1313', '590', '708', '890', '774', '889', '773', '772', '888', '765', '879') THEN 'Bony Fish'
 WHEN classKey IN ('131') THEN 'Amphibians'
 WHEN classKey IN ('216') THEN 'Insects'
 WHEN classKey IN ('11418114', '11569602', '11592253', '11493978') THEN 'Reptiles'
 WHEN phylumKey IN ('52') THEN 'Molluscs'
 WHEN classKey IN ('367') THEN 'Arachnids'
 WHEN classKey IN ('220', '196') THEN 'Flowering Plants'
 WHEN classKey IN ('194', '244', '228', '282') THEN 'Gymnosperms'
 WHEN orderKey IN ('392') THEN 'Ferns'
 WHEN phylumKey IN ('35') THEN 'Mosses'
 WHEN phylumKey IN ('95') THEN 'Sac Fungi'
 WHEN phylumKey IN ('34') THEN 'Basidiomycota'
 END AS taxonomic_group,
 COUNT(DISTINCT speciesKey) AS species_count
FROM occurrence
WHERE countryCode = 'SR'
 AND hasCoordinate = TRUE
 AND hasGeospatialIssues = FALSE
 AND coordinateUncertaintyInMeters &lt;= 2000
 AND occurrenceStatus = 'PRESENT'
 AND speciesKey IS NOT NULL
 AND basisOfRecord != 'FOSSIL_SPECIMEN'
 AND taxonRank = 'SPECIES'
 AND (
 classKey IN ('359', '212', '131', '216', '11418114', '11569602', '11592253', '11493978', '367', '220', '196', '194', '244', '228', '282')
 OR familyKey IN ('1103', '1104', '494', '495', '1105', '496', '497', '1106', '498', '499', '1107', '537', '538', '1153', '547', '1162', '548', '549', '550', '1163', '1164', '1165', '1166', '1167', '1305', '1067', '1306', '1307', '1308', '1068', '1069', '587', '1310', '588', '589', '1311', '1312', '1313', '590', '708', '890', '774', '889', '773', '772', '888', '765', '879')
 OR phylumKey IN ('52', '35', '95', '34')
 OR orderKey IN ('392')
 )
GROUP BY geogrid_id, taxonomic_group;


 The dataset's 270 records were derived from 84 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0003308-260226173443078/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25549/satjrnl-m291
title: Zritel', vol. 1, no. 3 (1905)

description: [description (english with transliteration)] Zritel' [Spectator], no. 3, June 19, 1905. Weekly. Published and edited by Iu. K. Artsybushev. St. Petersburg. Typography: "Sever" of A. M. Lesman. Journal of political-social satire -- BPIR, no. 3230; Rudzinskii, no. 53.; Editor-publisher: Iu.K. Artsybushev; members of the editorial board: G.E. Gints, I.Ia. Kagan, N.I. Faleev.
DOI: 10.17605/osf.io/7m5nr
title: SOLUS-D - Predictors and Moderators

description: In the SOLUS-D project, the efficacy of an Internet-based cognitive behavioral intervention for loneliness was examined. This RCT included two intervention conditions, i.e., ICBT with guidance and ICBT with automated messages, and a waitlist-control condition. In a secondary analysis potential predictors and moderators of treatment outcome and response were investigated. Here, the R-scripts and data supporting the publication on predictors and moderators are made available.

The associated publication can be found via: https://doi.org/10.1016/j.invent.2023.100701
DOI: 10.25934/00000130
title: A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)

description: This study is being conducted to evaluate the effectiveness and safety of LAMICTAL added to the current therapy of pediatric patients age 1-24 months old with partial seizures. The medication used in this study has been approved by FDA for the adjunctive treatment of partial seizures in patients 2 years and older.
DOI: 10.25934/00000131
title: A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Evaluation of Lamotrigine Adjunctive Therapy in Subjects Wtih Primary Generalized Tonic-Clonic Seizures

description: The purpose of this study is to evaluate the effectiveness and safety of an investigational new drug for supplemental therapy in subjects with primary generalized tonic-clonic (PGTC) seizures.
DOI: 10.25934/00000160
title: A Multicenter, Double-blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-Release Adjunctive Therapy in Patients With Primary Generalized Tonic-Clonic Seizures

description: This study is being conducted to compare the efficacy and safety of LAMICTAL (lamotrigine) extended-release with placebo in the treatment of Primary Generalized Tonic-Clonic (PGTC) seizures. LAMICTAL extended-release is an investigational drug. Placebo tablets look like LAMICTAL extended-release tablets but do not contain active medication. In this study, LAMICTAL extended-release or placebo tablets will be added to current seizure treatments.
DOI: 10.25934/00000248
title: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Phase 3 Study to Determine the Efficacy and Safety of Retigabine (1200 mg/Day) Used as Adjunctive Therapy in Refractory Epilepsy Patients With Partial-Onset Seizures

description: This Phase 3 study is being conducted to evaluate the efficacy and safety of retigabine dosed at 1200 mg/day, in three equally divided doses, compared with placebo in patients with epilepsy who are receiving up to three established antiepileptic drugs (AEDs).
DOI: 10.25934/00000249
title: Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Phase 3 Study - Determine Efficacy and Safety of Two Doses of Retigabine (900 Mg/Day and 600 Mg/Day) Used as Adjunctive Therapy in Refractory Epilepsy Patients With Partial-Onset Seizures

description: This Phase 3 study is being conducted to evaluate the efficacy and safety of retigabine dosed at 900 mg/day and 600 mg/day, in three equally divided doses, compared with placebo in patients with epilepsy who are receiving up to three established antiepileptic drugs (AEDs).
DOI: 10.25934/00000310
title: A Multicenter, Open-Label, Long-Term, Safety, Tolerability and Efficacy Study of Retigabine in Adult Epilepsy Patients With Partial-Onset Seizures (Extension of Study VRX-RET-E22-302)

description: This Phase 3 trial is an open-label extension study of the placebo-controlled, double-blind VRX-RET-E22-302 trial. Patients who have completed the VRX-RET-E22-302 trial and who meet inclusion and exclusion criteria will be treated with 600-1200 mg/day of retigabine as an adjunct therapy to their current antiepileptic drugs (AEDs) or vagal nerve stimulation. Treatment will be continued until the subject withdraws from the study or until the program is discontinued. Patients will be recruited from 55-60 sites in Europe, Israel, Australia, and South Africa. The primary objective of the study is to evaluate the safety and tolerability of long-term therapy with retigabine administered as adjunctive therapy in adult epilepsy patients with partial-onset seizures, who completed the double-blind Study VRX-RET-E22-302. Secondary objectives are: to evaluate efficacy of long-term treatment with retigabine and patient quality of life and to evaluate whether retinal pigmentation, unexplained vision loss, pigmentation of non-retinal ocular tissue, and discoloration of nails, lips, skin or mucosa change over time after discontinuation of retigabine.
DOI: 10.25934/00001163
title: A Randomised, Double-blind, Placebo-controlled, Parallel-group, Multicentre Study to Determine the Efficacy and Safety of 2 Doses of Retigabine Immediate Release (900 mg/Day and 600 mg/Day) Used as Adjunctive Therapy in Adult Asian Subjects With Drug-resistant Partial-onset Seizures.

description: The immediate release (IR) formulation of retigabine has been shown to be superior to placebo as adjunctive therapy in 3 adequate and well-controlled studies in subjects with drug-resistant partial-onset seizures (POS) who had previously failed to respond to two or more antiepileptic drugs (AEDs) and were still having seizures despite current treatment with 1, 2, or 3 AEDs. However, of 1244 subjects randomly assigned to treatment in these 3 clinical studies, only 10 were Asian subjects and only 5 of these Asian subjects were randomly assigned to treatment with retigabine. Therefore, this Phase III study is being conducted to evaluate the efficacy, safety and tolerability, and health outcomes of retigabine, at doses of 900 mg/day and 600 mg/day, compared with placebo in adult Asian subjects with drug-resistant POS.
DOI: 10.25934/00001412
title: A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures

description: This study is being conducted to compare the efficacy and safety of LAMICTAL (lamotrigine) extended-release with placebo in the treatment of partial seizures. LAMICTAL extended-release is an investigational drug. Placebo tablets look like LAMICTAL extended-release tablets but do not contain active medication. In this study, LAMICTAL extended-release or placebo tablets will be added to current seizure treatments.
DOI: 10.25934/00001625
title: Double-blind Randomized Trial of Cognitive Effects of LAMICTAL (lamotrigine) versus Topiramate in Epilepsy

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00001631
title: A Multicenter, Double-Blind, Placebo-Controlled, Parallel-Design Evaluation of LAMICTAL for Add-on Treatment of Partial Seizures in Pediatric Patients


description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00001994
title: Lamotrigine as add-on therapy in patients with a clinical diagnosis of a Lennox-Gastaut syndrome (severe generalised epilepsy of childhood onset). A multicentre, double-blind, placebo-controlled, parallel group study.


description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002037
title: An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)

description: This study will evaluate the long-term safety of LAMICTAL(lamotrigine)in subjects with partial seizures previously enrolled in protocol LAM20006 and in subjects 1-24 months of age who have never received LAMICTAL(LAMICTAL-naive). For LAMICTAL-naive subjects, LAMICTAL will be added to the subject's current epilepsy medications.